Auchter Allison M, Barrett Douglas W, Monfils Marie H, Gonzalez-Lima F
Department of Psychology, Institute for Neuroscience, The University of Texas at Austin, Austin, TX, United States.
Front Cell Neurosci. 2020 May 20;14:130. doi: 10.3389/fncel.2020.00130. eCollection 2020.
Chronic cerebral hypoperfusion in neurocognitive disorders diminishes cytochrome oxidase activity leading to neurodegenerative effects and impairment of learning and memory. Methylene blue at low doses stimulates cytochrome oxidase activity and may thus counteract the adverse effects of cerebral hypoperfusion. However, the effects of methylene blue on cytochrome oxidase activity during chronic cerebral hypoperfusion have not been described before. To test this hypothesis, rats underwent bilateral carotid artery occlusion or sham surgery, received daily 4 mg/kg methylene blue or saline injections, and learned a visual water task. Brain mapping of cytochrome oxidase activity was done by quantitative enzyme histochemistry. Permanent carotid occlusion for 1 month resulted in decreased cytochrome oxidase activity in visual cortex, prefrontal cortex, perirhinal cortex, hippocampus and amygdala, and weaker interregional correlation of cytochrome oxidase activity between these regions. Methylene blue preserved cytochrome oxidase activity in regions affected by carotid occlusion and strengthened their interregional correlations of cytochrome oxidase activity, which prevented neurodegenerative effects and facilitated task-specific learning and memory. Brain-behavior correlations revealed positive correlations between performance and brain regions in which cytochrome oxidase activity was preserved by methylene blue. These results are the first to demonstrate that methylene blue prevents neurodegeneration and memory impairment by preserving cytochrome oxidase activity and interregional correlation of cytochrome oxidase activity in brain regions susceptible to chronic hypoperfusion. This demonstration provides further support for the hypothesis that lower cerebral blood flow results in an Alzheimer's-like syndrome and that stimulating cytochrome oxidase activity with low-dose methylene blue is neuroprotective.
神经认知障碍中的慢性脑灌注不足会降低细胞色素氧化酶活性,导致神经退行性变以及学习和记忆受损。低剂量亚甲蓝可刺激细胞色素氧化酶活性,因此可能抵消脑灌注不足的不良影响。然而,此前尚未描述过亚甲蓝在慢性脑灌注不足期间对细胞色素氧化酶活性的影响。为了验证这一假设,对大鼠进行双侧颈动脉闭塞或假手术,每天给予4mg/kg亚甲蓝或生理盐水注射,并让它们学习视觉水迷宫任务。通过定量酶组织化学对细胞色素氧化酶活性进行脑图谱分析。永久性颈动脉闭塞1个月导致视觉皮层、前额叶皮层、鼻周皮层、海马体和杏仁核中的细胞色素氧化酶活性降低,且这些区域之间细胞色素氧化酶活性的区域间相关性减弱。亚甲蓝可保留受颈动脉闭塞影响区域的细胞色素氧化酶活性,并增强其细胞色素氧化酶活性的区域间相关性,从而防止神经退行性变并促进特定任务的学习和记忆。脑-行为相关性分析显示,行为表现与亚甲蓝保留了细胞色素氧化酶活性的脑区之间呈正相关。这些结果首次证明,亚甲蓝通过保留易受慢性灌注不足影响的脑区中的细胞色素氧化酶活性以及细胞色素氧化酶活性的区域间相关性,预防神经退行性变和记忆障碍。这一证明为以下假设提供了进一步支持:脑血流量降低会导致类似阿尔茨海默病的综合征,而用低剂量亚甲蓝刺激细胞色素氧化酶活性具有神经保护作用。